Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus

Andrea Stabile(Fondazione IRCCS Istituto Neurologico Carlo Besta), Leonello Avalli(Mario Negri Institute for Pharmacological Research), Giada Padovano(Mario Negri Institute for Pharmacological Research), G. Bogliun(Institute of Neurological Sciences), Anna Coppo(Mario Negri Institute for Pharmacological Research), Simone Beretta(Azienda Ospedaliera San Gerardo), Carlo Ferrarese(Azienda Ospedaliera San Gerardo)
Neurology Clinical Practice
January 6, 2020
10.1212/cpj.0000000000000740
Cited by 1

Related Papers

Behavioral and Psychological Effects of Coronavirus Disease-19 Quarantine in Patients With Dementia
|Frontiers in Psychiatry|2020|381
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
|The Lancet Neurology|2011|344
Guillain-Barré syndrome related to COVID-19 infection
|Neurology Neuroimmunology & Neuroinflammation|2020|340
Incidence and predictors of acute symptomatic seizures after stroke
|Neurology|2011|271
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection
|Nature Genetics|2014|236